Skip to main content
Premium Trial:

Request an Annual Quote

John DelliSanti, Robert Steininger

Premium
Caliper Life Sciences announced this week that John DelliSanti will be the company’s new executive vice president and chief commercial officer. In this position, DelliSanti will be in charge of Caliper’s worldwide sales, marketing and services efforts.
 
Prior to joining Caliper, DelliSanti led commercial operations at Invitrogen and held various positions at the chemical software and informatics company Accelrys.
 

 
Biopharmaceutical company Acceleron Pharma announced last week the appointment of Robert Steininger as senior VP of Manufacturing.
 
Previously, Steininger was VP of process sciences at Millennium Pharmaceuticals, and held multiple positions at Genetics Institute, now Wyeth Pharmaceuticals, from 1984 to 2000.

Filed under

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.